Exploring the role of serum uric acid as a biomarker in patients with schizophrenia, bipolar affective disorder, and major depressive disorder

Abstract Background Uric acid plays a pivotal role in the regulation of mood and behavior. The study aimed to elucidate the role of serum uric acid as a biomarker in patients with schizophrenia, bipolar affective disorder (BAD), and major depressive disorder (MDD) and to examine its relation to symp...

Full description

Bibliographic Details
Main Authors: Nermin Mahmoud Shaker, Doha el Serafi, Riham Hossam E. L.-Din Mahfouz, Mohamed Hossam El-din abd el moneam
Format: Article
Language:English
Published: SpringerOpen 2023-04-01
Series:Middle East Current Psychiatry
Subjects:
Online Access:https://doi.org/10.1186/s43045-023-00307-3
_version_ 1797850233457082368
author Nermin Mahmoud Shaker
Doha el Serafi
Riham Hossam E. L.-Din Mahfouz
Mohamed Hossam El-din abd el moneam
author_facet Nermin Mahmoud Shaker
Doha el Serafi
Riham Hossam E. L.-Din Mahfouz
Mohamed Hossam El-din abd el moneam
author_sort Nermin Mahmoud Shaker
collection DOAJ
description Abstract Background Uric acid plays a pivotal role in the regulation of mood and behavior. The study aimed to elucidate the role of serum uric acid as a biomarker in patients with schizophrenia, bipolar affective disorder (BAD), and major depressive disorder (MDD) and to examine its relation to symptom domains and severity of illness. Results A total of 150 participants with schizophrenia, BAD, and MDD and 50 healthy controls were recruited. Patients were assessed using Structured Clinical Interview for DSM-IV Axis I Diagnosis (SCID-I), Positive and Negative Syndrome Scale (PANSS), the Young Mania Rating Scale (YMRS), and the Hamilton Depression Rating Scale (HAM-D). General Health Questionnaire (GHQ-28) was applied to healthy controls. Then, a blood draw from all participants was performed to measure serum uric acid level. According to this study, there was a statistically significant difference between patients with schizophrenia, BAD, MDD, and healthy controls, with regard to serum uric acid level (P = 0.007). On correlating symptom domains and severity of schizophrenia, bipolar, and MDD with serum uric acid level, there was only a statistically significant negative correlation between YMRS and serum uric acid level (P = 0.022). Conclusions Serum uric acid could be a valuable biomarker in patients with schizophrenia, bipolar, and MDD especially in patients with bipolar disorder.
first_indexed 2024-04-09T18:57:06Z
format Article
id doaj.art-6f235e23b4ca41fb887462997f2fb2fb
institution Directory Open Access Journal
issn 2090-5416
language English
last_indexed 2024-04-09T18:57:06Z
publishDate 2023-04-01
publisher SpringerOpen
record_format Article
series Middle East Current Psychiatry
spelling doaj.art-6f235e23b4ca41fb887462997f2fb2fb2023-04-09T11:06:55ZengSpringerOpenMiddle East Current Psychiatry2090-54162023-04-013011810.1186/s43045-023-00307-3Exploring the role of serum uric acid as a biomarker in patients with schizophrenia, bipolar affective disorder, and major depressive disorderNermin Mahmoud Shaker0Doha el Serafi1Riham Hossam E. L.-Din Mahfouz2Mohamed Hossam El-din abd el moneam3Okasha Institute of Psychiatry, Ain Shams UniversityOkasha Institute of Psychiatry, Ain Shams UniversityOkasha Institute of Psychiatry, Ain Shams UniversityOkasha Institute of Psychiatry, Ain Shams UniversityAbstract Background Uric acid plays a pivotal role in the regulation of mood and behavior. The study aimed to elucidate the role of serum uric acid as a biomarker in patients with schizophrenia, bipolar affective disorder (BAD), and major depressive disorder (MDD) and to examine its relation to symptom domains and severity of illness. Results A total of 150 participants with schizophrenia, BAD, and MDD and 50 healthy controls were recruited. Patients were assessed using Structured Clinical Interview for DSM-IV Axis I Diagnosis (SCID-I), Positive and Negative Syndrome Scale (PANSS), the Young Mania Rating Scale (YMRS), and the Hamilton Depression Rating Scale (HAM-D). General Health Questionnaire (GHQ-28) was applied to healthy controls. Then, a blood draw from all participants was performed to measure serum uric acid level. According to this study, there was a statistically significant difference between patients with schizophrenia, BAD, MDD, and healthy controls, with regard to serum uric acid level (P = 0.007). On correlating symptom domains and severity of schizophrenia, bipolar, and MDD with serum uric acid level, there was only a statistically significant negative correlation between YMRS and serum uric acid level (P = 0.022). Conclusions Serum uric acid could be a valuable biomarker in patients with schizophrenia, bipolar, and MDD especially in patients with bipolar disorder.https://doi.org/10.1186/s43045-023-00307-3Serum uric acidSchizophreniaBipolarMajor depressive disorderBiomarkerPurinergic pathway
spellingShingle Nermin Mahmoud Shaker
Doha el Serafi
Riham Hossam E. L.-Din Mahfouz
Mohamed Hossam El-din abd el moneam
Exploring the role of serum uric acid as a biomarker in patients with schizophrenia, bipolar affective disorder, and major depressive disorder
Middle East Current Psychiatry
Serum uric acid
Schizophrenia
Bipolar
Major depressive disorder
Biomarker
Purinergic pathway
title Exploring the role of serum uric acid as a biomarker in patients with schizophrenia, bipolar affective disorder, and major depressive disorder
title_full Exploring the role of serum uric acid as a biomarker in patients with schizophrenia, bipolar affective disorder, and major depressive disorder
title_fullStr Exploring the role of serum uric acid as a biomarker in patients with schizophrenia, bipolar affective disorder, and major depressive disorder
title_full_unstemmed Exploring the role of serum uric acid as a biomarker in patients with schizophrenia, bipolar affective disorder, and major depressive disorder
title_short Exploring the role of serum uric acid as a biomarker in patients with schizophrenia, bipolar affective disorder, and major depressive disorder
title_sort exploring the role of serum uric acid as a biomarker in patients with schizophrenia bipolar affective disorder and major depressive disorder
topic Serum uric acid
Schizophrenia
Bipolar
Major depressive disorder
Biomarker
Purinergic pathway
url https://doi.org/10.1186/s43045-023-00307-3
work_keys_str_mv AT nerminmahmoudshaker exploringtheroleofserumuricacidasabiomarkerinpatientswithschizophreniabipolaraffectivedisorderandmajordepressivedisorder
AT dohaelserafi exploringtheroleofserumuricacidasabiomarkerinpatientswithschizophreniabipolaraffectivedisorderandmajordepressivedisorder
AT rihamhossameldinmahfouz exploringtheroleofserumuricacidasabiomarkerinpatientswithschizophreniabipolaraffectivedisorderandmajordepressivedisorder
AT mohamedhossameldinabdelmoneam exploringtheroleofserumuricacidasabiomarkerinpatientswithschizophreniabipolaraffectivedisorderandmajordepressivedisorder